ACHV
Achieve Life Sciences Inc
7.80$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 90.0% | 87.7% | 96.7% | 96.5% | 95.0% | 94.4% | 91.4% | 96.6% | 96.2% | 95.5% | 93.8% | 98.9% | |
| 81.6% | 80.3% | 94.8% | 22.8% | 19.9% | 33.0% | 47.6% | 88.0% | 61.4% | 50.1% | 84.8% | 25.2% | |
| 81.6% | 80.3% | 94.8% | 94.6% | 89.6% | 88.9% | 85.0% | 94.0% | 92.5% | 87.1% | 88.4% | 98.4% | |
| 0.3% | 0.6% | – | – | – | – | – | – | – | – | – | – | |
| 0.2% | – | – | – | – | – | – | – | – | – | – | – | |
| 4.2% | 5.3% | 1.5% | 1.6% | 2.2% | 2.7% | 3.8% | 1.8% | 2.0% | 2.5% | 3.1% | 0.5% | |
| 5.1% | 6.2% | 1.6% | 1.7% | 2.1% | 2.5% | 3.4% | 1.5% | 1.6% | 1.8% | 2.1% | 0.1% | |
| 83.4% | 107.5% | 29.4% | 34.7% | 34.5% | 45.9% | 62.4% | 29.3% | 35.4% | 48.5% | 67.7% | 107.7% | |
| 16.8% | 107.4% | 29.4% | 21.1% | 14.0% | 17.3% | 26.1% | 14.5% | 18.7% | 21.7% | 35.7% | 103.8% | |
| 0.3% | 86.3% | 24.6% | 13.6% | 0.0% | 0.1% | 4.6% | 2.1% | 2.4% | 9.0% | 17.0% | 3.9% | |
| 2.6% | 3.2% | 0.5% | 0.8% | 2.1% | 5.0% | 6.1% | 2.1% | 3.7% | 2.1% | 2.5% | 0.3% | |
| 66.5% | – | – | 13.6% | 20.5% | 25.5% | 31.6% | 14.7% | 16.7% | 26.8% | 28.2% | 3.9% | |
| 16.6% | -7.5% | 70.6% | 65.3% | 65.5% | 54.1% | 37.6% | 70.7% | 64.6% | 51.5% | 32.3% | -7.7% | |
| -658.6% | -855.7% | -246.0% | -278.9% | -403.2% | -532.1% | -798.3% | -392.2% | -471.9% | -622.7% | -816.8% | -181.2% | |
| 86.8% | 109.3% | 35.8% | 53.0% | 71.7% | 89.3% | 126.8% | 58.9% | 98.0% | 127.5% | 161.3% | 49.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.